Parkinson's Disease

Aarsland D, Bronnick K, Williams-Gray C et al (2010) Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology 75: 1062-1069.


Allcock L M, Kenny R A, Mosimann U P, Tordoff S, Wesnes K A, Hildreth A J and Burn D J (2006). Orthostatic hypotension in Parkinson's disease: association with cognitive decline? International Journal of Geriatric Psychiatry. 21: 778-783.


Allcock L M, Rowan E N, Steen I N, Wesnes K A, Kenny R A and Burn D J (2009). Impaired attention predicts falling in Parkinson’s disease. Parkinsonism and Related Disorders. 15: 110-115.


Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, O’Brien JT (2003). MRI Study of Caudate Nucleus Volume in Parkinson’s Disease with and without Dementia with Lewy Bodies and Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 16: 57-63.


Hudson G, Stutt A, Eccles M, Robinson L, Allcock LM, Wesnes KA, Chinnery PF, Burn DJ (2010). Genetic variation of CHRNA4 does not modulate attention in Parkinson's Disease. Neuroscience Letters 479: 123-125.


Litvan I, Aarsland D, Mayeux R et al (2011) MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI. Movement Disorders 26: 1814–1824.


Mace J, Porter R, Dalrymple-Alford J, Wesnes KA, Anderson T (2009). Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease. Journal of Psychopharmacology doi:10.1177/0269881109105721.


Molloy S, Rowan EN, O'Brien JT, McKeith IG, Wesnes KA, Burn DJ (2006). The effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of Neurology Neurosurgery & Psychiatry. 77: 1323-1328.


Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG (2004). Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology. 63: 2091-2096.


Taylor JP, Rowan EN, Lett D, O'Brien JT, McKeith IG, Burn D (2008). Poor attentional function predicts cognitive decline in non-demented Parkinson's disease patients independent of motor phenotype. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 1318-1323.


Thevathasan W, Silburn PA, Brooker H, Coyne TJ, Khan S, Gill SS, Aziz TZ, Brown P (2010). The impact of low-frequency stimulation of the pedunculopontine nucleus region on reaction time in Parkinsonism. J Neurol Neurosurg Psychiatry 2010;81:1099-1104 doi:10.1136/jnnp.2009.189324 


Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela-Otero C, Rowe J, Mollenhauer B, Hudson G, Chinnery PF, O’Brien JT, Robbins TW, Wesnes KA, Brooks DJ, Barker RA, Burn JA (2014). Characterising Mild Cognitive Impairment in Incident Parkinson’s Disease: The ICICLE-

PD Study. Neurology 82: 308-316.


Wesnes KA, Aarsland D, Ballard C, Londos E. (2014). Memantine improves attention and verbal episodic memory in patients with Parkinson's disease dementia and dementia with Lewy bodies: A randomised, double-blind, placebo-controlled, multicentre trial. International Journal of Geriatric Psychiatry

DOI: 10.1002/gps.4109


Wesnes KA, Burn DJ. (2013). Compromised object pattern separation performance in Parkinson’s disease suggests dentate gyrus neurogenesis may be compromised in the condition. Journal of Alzheimer's Disease & Parkinsonism 3: 131. doi: 10.4172/2161-0460.1000131

Get in touch...




  • Twitter B&W